The American Cancer Society is the lead institution for promoting the Merck vaccine called Gardasil
Details of the ACIP recommendations for GARDASIL
9 will be available from the CDC.
In September 2005, seven months before FDA approval of its Gardasil
vaccine, Merck commenced a direct-to-consumer marketing campaign that connected the human papilloma virus (HPV) to cervical cancer.
The US Food and Drug Administration (FDA) recently extended the approval for Gardasil
9 (to prevent HPV-associated cancers, cancer precursors, and genital lesions) to men and women aged 27 to 45.
The vaccine (Gardasil
9) was previously approved for those aged 9-26 years.
Food and Drug Administration has expanded coverage of the HPV vaccine Gardasil
9 to include patients between the ages of 27 and 45.
M2 EQUITYBITES-October 9, 2018-Merck receives US FDA approval to expand Gardasil
Food and Drug Administration approval of the Gardasil
9 human papillomavirus (HPV) vaccine has been expanded to include people ages 27 through 45, the agency said in a news release.
Global Banking News-October 8, 2018-The US Food and Drug Administration approves the expanded use of Gardasil
Food and Drug Administration approved Gardasil
for use in girls and young women, ages 9-26, to prevent certain cancers and diseases caused by four HPV types.